Gender differences in the outcome of noninvasive cardiovascular treatment

Italian Heart Journal

Volumn 4, Issue 8, 2003, Pages 514-517

  Penco, Maria ^a   Fratini, Simona ^a   Romano, Silvio ^a   Novo, Salvatore ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Coronary heart disease; Hormones; Prevention

Indexed keywords

COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 1542680144     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-90.
2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring Trends and Determinants in Cardiovascular Disease. Lancet 1999; 353: 1547-57.
3. Lowe LP, Greenland P, Ruth RJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med 1998; 158: 2007-14.
4. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159: 1104-9.
5. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adults and middle-aged men and women. JAMA 1999; 282: 2012-8.
6. Grover SA, Paquet S, Levinton C, Coupal L, Zowall H. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary versus secondary prevention. Arch Intern Med 1998; 158: 655-62.
7. Perlman JA, Wolf PH, Ray R, Lieberknecht G. Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California women. Am J Obstet Gynecol 1988; 158 (Part 2): 1568-74.
8. Newnham HH, Silberberg J. Coronary heart disease. Women's hearts are hard to break. Lancet 1997; 349 (Suppl 1): SI3-SI6.
9. National Center for Health Statistics. Health, United States, 1990. Hyattsville, MD: Public Health Service, 1991.
10. Weiner DA, Ryan TJ, McCabe CH, et al. Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med 1979; 301: 230-5.
11. Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle aged men and women. The Framingham Study. Arch Intern Med 1996; 156: 505-9.
12. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med 1999; 14: 711-7.
13. Collins LJ, Douglas PS. Acute coronary syndromes. In: Charney P, ed. Coronary artery disease in women: prevention, diagnosis and management. Philadelphia, PA: American College of Physicians, 1999: 407-13.
14. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341: 226-32.
15. Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C. Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J 1984; 5: 374-81.
16. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152: 972-6.
17. Dellborg M, Herlitz J, Emanuelsson H, Swedberg K. ECG changes during myocardial ischemia. Differences between men and women. J Electrocardiol 1994; 27 (Suppl): 42-5.
18. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation 1991; 83: 484-91.
19. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000; 343: 8-15.
20. Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9: 473-82.
21. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction. Biology or methodology? JAMA 1990; 263: 1092-6.
22. Klein W. Cardiovascular disease at the turn of the millennium: focus in Europe. Eur Heart J 2001; 3 (Suppl M): M2-M6.
23. Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158: 981-8.
24. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-25.
25. Woodfield SL, Lundergan CF, Reiner SJ, et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol 1997; 29: 35-42.
26. Fair JM, Berra K, King AC. Exercise as primary and secondary prevention. In: Charney P, ed. Coronary artery disease in women: prevention, diagnosis and management. Philadelphia, PA: American College of Physicians, 1999: 209-35.
27. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11.
28. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769-75.
29. Session DR, Kelly AC, Jewelewicz R. Current concepts in estrogen replacement therapy in the menopause. Fertil Steril 1993; 2: 277-84.
30. Rossouw JE, Anderson GL, Prentice RL, et al, for the Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
31. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-13.
32. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart an Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57.
33. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499-503.